Plain-English translation of NCT05223816 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new treatment called that is injected directly into tumors to fight liver cancer and bile duct cancer. Researchers want to see if works better when given by itself or when combined with an approved immunotherapy called nivolumab. The goal is to help patients whose cancer has continued to grow despite previous treatments.
Current treatments for advanced liver and bile duct cancers don't work for everyone, and many patients' cancers stop responding over time. This medication is designed to work differently โ by being injected directly into the tumor โ and researchers hope it may help patients who have already tried other therapies.
If you join this trial, you will receive injections of the medication directly into your tumor, usually over three days. Depending on which group you are in, you may receive this treatment alone or combined with intravenous infusions of nivolumab (an approved immunotherapy drug). You will have regular clinic visits for blood tests, imaging scans, and check-ups to see how the treatment is working and to monitor for any side effects.
AI-generated summary from trial data ยท Jun 25, 2026 ยท Not medical advice
United States